369 related articles for article (PubMed ID: 10772975)
1. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
2. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
[TBL] [Abstract][Full Text] [Related]
3. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
4. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches.
Alves Vianna CO; da Silva E Mouta Júnior S; da Glória Teixeira Martins M; Batoreu NM; Queiroz JL; Gomes SA; Magalhães de Andrade Góes AC; Garcia Armoa GR; Marques CH; Baroni de Moraes MT
J Immunol Methods; 2006 Jun; 313(1-2):38-47. PubMed ID: 16753174
[TBL] [Abstract][Full Text] [Related]
7. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site.
Wi J; Jeong MS; Hong HJ
J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
9. Selection of an affinity-matured antibody against a defined epitope by phage display of an immune antibody library.
Kim SJ; Jang MH; Ahn HJ; Kim JH; Lim JH; Ryu CJ; Lim NK; Kim KS; Park MJ; Park I; Hong HJ
J Immunol Methods; 2008 Jan; 329(1-2):176-83. PubMed ID: 18021795
[TBL] [Abstract][Full Text] [Related]
10. Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli.
Maeng CY; Oh MS; Park IH; Hong HJ
Biochem Biophys Res Commun; 2001 Apr; 282(3):787-92. PubMed ID: 11401532
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
12. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody.
Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A
Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277
[TBL] [Abstract][Full Text] [Related]
13. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.
Xu X; Li GD; Kong YY; Yang HL; Zhang Z; Cao HT; Wang Y
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3673-7. PubMed ID: 7527840
[TBL] [Abstract][Full Text] [Related]
14. Attachment sites and neutralising epitopes of hepatitis B virus.
Glebe D
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703
[TBL] [Abstract][Full Text] [Related]
15. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
16. [Antigenic analysis of two chimeric hepatitis B core particles presenting the preS1 neutralizing epitopes].
Su QD; Guo MZ; Yi Y; Chen SY; Jia ZY; Lu XX; Qiu F; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):336-9. PubMed ID: 24645316
[TBL] [Abstract][Full Text] [Related]
17. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
[TBL] [Abstract][Full Text] [Related]
19. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
Ryu CJ; Gripon P; Park HR; Park SS; Kim YK; Guguen-Guillouzo C; Yoo OJ; Hong HJ
J Med Virol; 1997 Jun; 52(2):226-33. PubMed ID: 9179773
[TBL] [Abstract][Full Text] [Related]
20. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
